Thymopentin in the treatment of herpes zoster

M. Lomuto, P. Zenarola, G. Ditano, N. Cascavilla

Research output: Contribution to journalArticle

Abstract

The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.

Original languageEnglish
Pages (from-to)672-678
Number of pages7
JournalCurrent Therapeutic Research
Volume44
Issue number4
Publication statusPublished - 1988

Fingerprint

Thymopentin
Herpes Zoster
Aptitude
Secondary Prevention
Pharmaceutical Preparations
Therapeutics
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lomuto, M., Zenarola, P., Ditano, G., & Cascavilla, N. (1988). Thymopentin in the treatment of herpes zoster. Current Therapeutic Research, 44(4), 672-678.

Thymopentin in the treatment of herpes zoster. / Lomuto, M.; Zenarola, P.; Ditano, G.; Cascavilla, N.

In: Current Therapeutic Research, Vol. 44, No. 4, 1988, p. 672-678.

Research output: Contribution to journalArticle

Lomuto, M, Zenarola, P, Ditano, G & Cascavilla, N 1988, 'Thymopentin in the treatment of herpes zoster', Current Therapeutic Research, vol. 44, no. 4, pp. 672-678.
Lomuto, M. ; Zenarola, P. ; Ditano, G. ; Cascavilla, N. / Thymopentin in the treatment of herpes zoster. In: Current Therapeutic Research. 1988 ; Vol. 44, No. 4. pp. 672-678.
@article{c4c5271790e647c6baad32eeddaaa9a8,
title = "Thymopentin in the treatment of herpes zoster",
abstract = "The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.",
author = "M. Lomuto and P. Zenarola and G. Ditano and N. Cascavilla",
year = "1988",
language = "English",
volume = "44",
pages = "672--678",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Thymopentin in the treatment of herpes zoster

AU - Lomuto, M.

AU - Zenarola, P.

AU - Ditano, G.

AU - Cascavilla, N.

PY - 1988

Y1 - 1988

N2 - The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.

AB - The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.

UR - http://www.scopus.com/inward/record.url?scp=0023699907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023699907&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0023699907

VL - 44

SP - 672

EP - 678

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 4

ER -